Clinical Trials
2 trialsNCT00574977 2015-12-28
Safety Study of Modified Vaccinia Virus to Cancer
University of Pittsburgh
Phase 1 Completed
NCT00116597 2009-12-02
Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma
University Hospital, Basel, Switzerland
Phase 1/2 Completed